Lau et al. demonstrated a strong positive correlation between Nrf2 levels and resistance of three cancer cell lines to chemotherapeutic drugs such as cisplatin, doxorubicin, and etoposide [211]. The gene discussed is NFE2L2; the disease is cancer.